Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E POULSEN

Showing results (351-360 of 363) with videos related to

Pageof 37
Sort By:
Free Radical Biology & Medicine|November 25, 2021
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trialEmil List Larsen, Laura K Kjær, Louise Lundby-Christensen, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|November 16, 2021
Skeletal muscle adaptations to exercise are not influenced by metformin treatment in humans: secondary analyses of 2 randomized, clinical trialsNanna S Pilmark, Laura Oberholzer, Jens F Halling, et al.
European Journal of Haematology|September 2, 2022
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-upMorten K Larsen, Vibe Skov, Lasse Kjaer, et al.
Kidney International|December 4, 2019
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trialErik J M van Bommel, Marcel H A Muskiet, Michaël J B van Baar, et al.
Trials|April 2, 2021
The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the "DOSE-EX" multi-arm parallel-group randomised clinical trialMark P P Lyngbaek, Grit E Legaard, Sebastian L Bennetsen, et al.
Clinical Epidemiology|December 15, 2017
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient RegistryElse Helene Ibfelt, Jan Sørensen, Dorte V Jensen, et al.
Nature Communications|February 16, 2021
Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exerciseAnders B Klein, Trine S Nicolaisen, Niels Ørtenblad, et al.
Nature Metabolism|June 27, 2022
Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivoMichael P Murphy, Hülya Bayir, Vsevolod Belousov, et al.
Nature Genetics|November 14, 2025
Genome-wide association study and polygenic risk prediction of hypothyroidismSøren A Rand, Gustav Ahlberg, Vinicius Tragante, et al.
Plos One|November 27, 2024
Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workersAleksander Eiken, Sofie Bliddal, Marie Villumsen, et al.
Pageof 37

Showing results (351-360 of 363) with videos related to

Sort By:
Pageof 37
Free Radical Biology & Medicine|November 25, 2021
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trialEmil List Larsen, Laura K Kjær, Louise Lundby-Christensen, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|November 16, 2021
Skeletal muscle adaptations to exercise are not influenced by metformin treatment in humans: secondary analyses of 2 randomized, clinical trialsNanna S Pilmark, Laura Oberholzer, Jens F Halling, et al.
European Journal of Haematology|September 2, 2022
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-upMorten K Larsen, Vibe Skov, Lasse Kjaer, et al.
Kidney International|December 4, 2019
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trialErik J M van Bommel, Marcel H A Muskiet, Michaël J B van Baar, et al.
Trials|April 2, 2021
The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the "DOSE-EX" multi-arm parallel-group randomised clinical trialMark P P Lyngbaek, Grit E Legaard, Sebastian L Bennetsen, et al.
Clinical Epidemiology|December 15, 2017
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient RegistryElse Helene Ibfelt, Jan Sørensen, Dorte V Jensen, et al.
Nature Communications|February 16, 2021
Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exerciseAnders B Klein, Trine S Nicolaisen, Niels Ørtenblad, et al.
Nature Metabolism|June 27, 2022
Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivoMichael P Murphy, Hülya Bayir, Vsevolod Belousov, et al.
Nature Genetics|November 14, 2025
Genome-wide association study and polygenic risk prediction of hypothyroidismSøren A Rand, Gustav Ahlberg, Vinicius Tragante, et al.
Plos One|November 27, 2024
Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workersAleksander Eiken, Sofie Bliddal, Marie Villumsen, et al.
Pageof 37